SEER
Seer is a developer of a life sciences and health data platform intended to facilitate early, pre-symptomatic detection of chronic life-threatening diseases. The company's platform captures and translates molecular insights from the proteome with improved accuracy and speed, enabling healthcare professionals to detect cancer and neurological diseases, drive earlier treatment and improve patient outcomes.
SEER
Industry:
Biotechnology Health Care Life Science Medical
Founded:
2017-01-01
Status:
Active
Contact:
(650) 453-0000
Email Addresses:
[email protected]
Total Funding:
169.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Fidelity Management and Research Company
Fidelity Management and Research Company investment in Series D - Seer
Maverick Ventures
Maverick Ventures investment in Series D - Seer
aMoon Fund
aMoon Fund investment in Series D - Seer
HBM Healthcare Investments AG
HBM Healthcare Investments AG investment in Series D - Seer
Solasta Ventures
Solasta Ventures investment in Series D - Seer
Emerson Collective
Emerson Collective investment in Series D - Seer
T. Rowe Price
T. Rowe Price investment in Series D - Seer
Invus
Invus investment in Series D - Seer
Invus
Invus investment in Series D - Seer
Maverick Ventures
Maverick Ventures investment in Series D - Seer
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2020-09-15 | PrognomiQ | Seer investment in Venture Round - PrognomiQ | 55 M USD |